Insider · CIK 0001450485
Nancy Lurker
Files at COLL (COLLEGIUM PHARMACEUTICAL, INC), EYPT (EyePoint, Inc.), ALKS (Alkermes plc.). First filing Dec 1, 2025, latest May 15, 2026.
Nancy Lurker files SEC Form 4 as director at EYPT (EyePoint, Inc.), and also at COLL (COLLEGIUM PHARMACEUTICAL, INC), ALKS (Alkermes plc.). Since Dec 1, 2025, Nancy Lurker has reported 0 open-market buys worth $0 and 3 open-market sells worth $313k, the latest filed on May 15, 2026.
A track record needs three past buys with six months of prices behind them; Nancy Lurker has 0, so none is measured yet.
The newest scored trade: sold $162k of COLL on May 13, 2026, filed May 15, 2026, scored 46 (moderate). In the last 12 months: 0 buys worth $0 and 3 sells worth $313k.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
EYPT: EyePoint, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
COLL: COLLEGIUM PHARMACEUTICAL, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | COLLEGIUM PHARMACEUTICAL, INC | $162k 4,500 shares | -20% | +21% from low-30% from high | |
| 14Weak | EyePoint, Inc. | $140k 9,300 shares | -4% | - | |
| 3Weak | EyePoint, Inc. | $10k 700 shares | -0% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 4, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | 9,300 0.01% of outstanding | $140k | Dec 4, 2025 | $10k |
| Nov 28, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | 500 0.00% of outstanding | $7,475 | Nov 28, 2025 | $2,990 |
| Nov 26, 2025 | EYPT EyePoint Pharmaceuticals, Inc. | 200 0.00% of outstanding | $2,990 | Nov 26, 2025 | none |
Transactions
Every row this insider has filed, 50 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | ALKS Alkermes plc. | MOption exercise Ordinary Shares | +6,142 | - | - | 19,697 | May 22, 2026 |
| May 21, 2026 | ALKS Alkermes plc. | FTax withholding Ordinary Shares | -1,475 | $36.95 | $55k | 18,222 | May 22, 2026 |
| May 20, 2026 | ALKS Alkermes plc. | AGrant or award Non Qualified Stock Option (Right to Buy)derivative | +11,538 | $0.00 | $0 | 11,538 | May 22, 2026 |
| May 20, 2026 | ALKS Alkermes plc. | AGrant or award Restricted Stock Unit Awardderivative | +5,409 | $0.00 | $0 | 5,409 | May 22, 2026 |
| May 21, 2026 | ALKS Alkermes plc. | MOption exercise Restricted Stock Unit Awardderivative | -6,142 | - | - | 0 | May 22, 2026 |
| May 14, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +8,741 | $0.00 | $0 | 26,758 | May 18, 2026 |
| May 13, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock | -4,500 | $35.97 | $162k | 18,017 | May 15, 2026 |
| Apr 11, 2026 | ALKS Alkermes plc. | MOption exercise Ordinary Shares | +3,751 | - | - | 14,456 | Apr 13, 2026 |
| Apr 11, 2026 | ALKS Alkermes plc. | FTax withholding Ordinary Shares | -901 | $33.36 | $30k | 13,555 | Apr 13, 2026 |
| Apr 11, 2026 | ALKS Alkermes plc. | MOption exercise Restricted Stock Unit Awardderivative | -3,751 | - | - | 3,752 | Apr 13, 2026 |
| Jan 6, 2026 | EYPT EyePoint, Inc. | MOption exercise Common Stock | +75,133 | $0.00 | $0 | 294,346 | Jan 7, 2026 |
| Jan 6, 2026 | EYPT EyePoint, Inc. | MOption exercise Restricted Stock Unitsderivative | -75,133 | $0.00 | $0 | 0 | Jan 7, 2026 |
| Jan 5, 2026 | EYPT EyePoint, Inc. | MOption exercise Common Stock | +12,666 | $0.00 | $0 | 219,213 | Jan 6, 2026 |
| Jan 2, 2026 | EYPT EyePoint, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jan 6, 2026 |
| Jan 5, 2026 | EYPT EyePoint, Inc. | MOption exercise Restricted Stock Unitsderivative | -12,666 | $0.00 | $0 | 12,667 | Jan 6, 2026 |
| Dec 4, 2025 | EYPT EyePoint, Inc. | SOpen-market sale Common Stock10b5-1 | -9,300 | $15.11 | $140k | 206,547 | Dec 5, 2025 |
| Nov 26, 2025 | EYPT EyePoint, Inc. | SOpen-market sale Common Stock10b5-1 | -200 | $14.95 | $2,990 | 216,347 | Dec 1, 2025 |
| Nov 28, 2025 | EYPT EyePoint, Inc. | SOpen-market sale Common Stock10b5-1 | -500 | $14.95 | $7,475 | 215,847 | Dec 1, 2025 |
| Jul 10, 2025 | EYPT EyePoint, Inc. | MOption exercise Common Stock | +11,111 | $0.00 | $0 | 216,547 | Jul 11, 2025 |
| Jul 10, 2025 | EYPT EyePoint, Inc. | MOption exercise Restricted Stock Unitsderivative | -11,111 | $0.00 | $0 | 11,112 | Jul 11, 2025 |
| Jul 2, 2025 | EYPT EyePoint, Inc. | GGift Stock Option (Right to Buy)derivative | -31,165 | $0.00 | $0 | 0 | Jul 2, 2025 |
| Jul 2, 2025 | EYPT EyePoint, Inc. | GGift Stock Option (Right to Buy)derivativeindirect: By Family Trust | +31,165 | $0.00 | $0 | 213,700 | Jul 2, 2025 |
| Jul 2, 2025 | EYPT EyePoint, Inc. | GGift Stock Option (Right to Buy)derivative | -55,000 | $0.00 | $0 | 40,000 | Jul 2, 2025 |
| Jul 2, 2025 | EYPT EyePoint, Inc. | GGift Stock Option (Right to Buy)derivativeindirect: By Family Trust | +55,000 | $0.00 | $0 | 200,000 | Jul 2, 2025 |
| Jul 2, 2025 | EYPT EyePoint, Inc. | GGift Stock Option (Right to Buy)derivative | -103,308 | $0.00 | $0 | 178,442 | Jul 2, 2025 |
| Jul 2, 2025 | EYPT EyePoint, Inc. | GGift Stock Option (Right to Buy)derivativeindirect: By Family Trust | +103,308 | $0.00 | $0 | 272,358 | Jul 2, 2025 |
| Jul 2, 2025 | EYPT EyePoint, Inc. | GGift Stock Option (Right to Buy)derivative | -15,278 | $0.00 | $0 | 34,722 | Jul 2, 2025 |
| Jul 2, 2025 | EYPT EyePoint, Inc. | GGift Stock Option (Right to Buy)derivativeindirect: By Family Trust | +15,278 | $0.00 | $0 | 31,944 | Jul 2, 2025 |
| Jul 2, 2025 | EYPT EyePoint, Inc. | GGift Stock Option (Right to Buy)derivative | -27,270 | $0.00 | $0 | 49,730 | Jul 2, 2025 |
| Jul 2, 2025 | EYPT EyePoint, Inc. | GGift Stock Option (Right to Buy)derivativeindirect: By Family Trust | +27,270 | $0.00 | $0 | 27,270 | Jul 2, 2025 |
| May 31, 2025 | ALKS Alkermes plc. | MOption exercise Ordinary Shares | +8,013 | - | - | 12,629 | Jun 2, 2025 |
| May 31, 2025 | ALKS Alkermes plc. | FTax withholding Ordinary Shares | -1,924 | $30.61 | $59k | 10,705 | Jun 2, 2025 |
| May 31, 2025 | ALKS Alkermes plc. | MOption exercise Restricted Stock Unit Awardderivative | -8,013 | - | - | 0 | Jun 2, 2025 |
| May 21, 2025 | ALKS Alkermes plc. | AGrant or award Non Qualified Stock Option (Right to Buy)derivative | +13,474 | $0.00 | $0 | 13,474 | May 23, 2025 |
| May 21, 2025 | ALKS Alkermes plc. | AGrant or award Restricted Stock Unit Awardderivative | +6,142 | $0.00 | $0 | 6,142 | May 23, 2025 |
| May 15, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +9,791 | $0.00 | $0 | 22,517 | May 19, 2025 |
| Apr 11, 2025 | ALKS Alkermes plc. | MOption exercise Ordinary Shares | +2,323 | - | - | 2,323 | Apr 14, 2025 |
| Apr 11, 2025 | ALKS Alkermes plc. | FTax withholding Ordinary Shares | -558 | $27.00 | $15k | 1,765 | Apr 14, 2025 |
| Apr 11, 2025 | ALKS Alkermes plc. | MOption exercise Ordinary Shares | +3,752 | - | - | 5,517 | Apr 14, 2025 |
| Apr 11, 2025 | ALKS Alkermes plc. | FTax withholding Ordinary Shares | -901 | $27.00 | $24k | 4,616 | Apr 14, 2025 |
| Apr 11, 2025 | ALKS Alkermes plc. | MOption exercise Restricted Stock Unit Awardderivative | -2,323 | - | - | 0 | Apr 14, 2025 |
| Apr 11, 2025 | ALKS Alkermes plc. | MOption exercise Restricted Stock Unit Awardderivative | -3,752 | - | - | 7,503 | Apr 14, 2025 |
| Feb 9, 2025 | EYPT EyePoint, Inc. | MOption exercise Common Stock | +20,000 | $0.00 | $0 | 205,436 | Feb 11, 2025 |
| Feb 9, 2025 | EYPT EyePoint, Inc. | MOption exercise Restricted Stock Unitsderivative | -20,000 | $0.00 | $0 | 0 | Feb 11, 2025 |
| Feb 4, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +12,726 | $0.00 | $0 | 12,726 | Feb 5, 2025 |
| Jan 5, 2025 | EYPT EyePoint, Inc. | MOption exercise Common Stock | +12,667 | $0.00 | $0 | 110,302 | Jan 7, 2025 |
| Jan 6, 2025 | EYPT EyePoint, Inc. | MOption exercise Common Stock | +75,134 | $0.00 | $0 | 185,436 | Jan 7, 2025 |
| Jan 3, 2025 | EYPT EyePoint, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jan 7, 2025 |
| Jan 5, 2025 | EYPT EyePoint, Inc. | MOption exercise Restricted Stock Unitsderivative | -12,667 | $0.00 | $0 | 25,333 | Jan 7, 2025 |
| Jan 6, 2025 | EYPT EyePoint, Inc. | MOption exercise Restricted Stock Unitsderivative | -75,134 | $0.00 | $0 | 75,133 | Jan 7, 2025 |
Questions about Nancy Lurker
Answered from the filings on this page, as of the latest one.
Is Nancy Lurker buying or selling?
In the last 12 months Nancy Lurker reported 0 open-market buys worth $0 and 3 open-market sells worth $313k on SEC Form 4; the latest was sold $162k of COLL on May 13, 2026. Grants, option exercises and tax withholding are not counted.
How did Nancy Lurker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nancy Lurker has 0.
Where does Nancy Lurker file Form 4?
Nancy Lurker has filed Form 4 at EYPT (EyePoint, Inc.); COLL (COLLEGIUM PHARMACEUTICAL, INC); ALKS (Alkermes plc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.